Antifungal Activity of Efinaconazole Compared with Fluconazole, Itraconazole, and Terbinafine Against Terbinafine- and Itraconazole-Resistant/Susceptible Clinical Isolates of Dermatophytes, Candida, and Molds

被引:4
|
作者
Gamal, Ahmed [1 ]
Elshaer, Mohammed [1 ,2 ]
Long, Lisa [1 ]
Mccormick, Thomas S. [1 ]
Elewski, Boni [3 ]
Ghannoum, Mahmoud A. [1 ,4 ]
机构
[1] Case Western Reserve Univ, Ctr Med Mycol & Integrated Microbiome Core, Dept Dermatol, Cleveland, OH USA
[2] Mansoura Univ, Fac Med, Clin Pathol Dept, Mansoura, Egypt
[3] Univ Birmingham, Dept Dermatol, Birmingham, AL USA
[4] Univ Hosp Cleveland Med Ctr, Cleveland, OH USA
关键词
SUPERFICIAL DERMATOPHYTOSIS; FUNGAL-INFECTIONS; CANDIDA-AURIS; RESISTANCE; VORICONAZOLE; MECHANISM; ALBICANS; TRIAZOLE;
D O I
10.7547/22-132
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background: Recently, an increasing number of resistant-to-terbinafine dermatophytosis cases have been reported. Thus, identifying an alternative antifungal agent that possesses broad-spectrum activity, including against resistant strains, is needed. Methods: We compared the antifungal activity of efinaconazole with that of fluconazole, itraconazole, and terbinafine against clinical isolates of dermatophytes, Candida, and molds using in vitro assays. Minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) of each antifungal agent were quantified and compared. Susceptible and resistant clinical isolates of Trichophyton mentagrophytes (n = 16), Trichophyton rubrum (n = 43), Trichophyton tonsurans (n = 18), Trichophyton violaceum (n = 4), Candida albicans (n = 55), Candida auris (n = 30), Fusarium spp, Scedosporium spp, and Scopulariopsis spp (n = 15 for each) were tested. Results: Efinaconazole was the most active antifungal agent tested against dermatophytes, with MIC50 and MIC90 (concentrations that inhibited 50% and 90% of strains tested, respectively) values of 0.002 and 0.03 mu g/mL, respectively. Fluconazole, itraconazole, and terbinafine showed MIC50 and MIC90 values of 1 and 8 mu g/mL, 0.03 and 0.25 mu g/mL, and 0.03 and 16 mu g/mL, respectively. Against Candida isolates, efinaconazole MIC50 and MIC90 values were 0.016 and 0.25 mu g/mL, respectively, whereas fluconazole, itraconazole, and terbinafine had MIC50 and MIC90 values of 1 and 16 mu g/mL, 0.25 and 0.5 mu g/mL, and 2 and 8 mu g/mL, respectively. Against various mold species, efinaconazole MIC values ranged from 0.016 to 2 mu g/mL versus 0.5 to greater than 64 mu g/mL for the comparators. Conclusions: Efinaconazole showed superior potent activity against a broad panel of susceptible and resistant dermatophyte, Candida, and mold isolates. (J Am Podiatr Med Assoc
引用
收藏
页数:8
相关论文
共 50 条
  • [41] In vitro activity of Luliconazole against fluconazole-susceptible and resistant isolates of Candida species
    Abastabar, M.
    Rahimi, N.
    Hedatyati, M. T.
    Makimura, K.
    Rezaei-Matehkolaei, A.
    Shokohi, T.
    Moazeni, M.
    Haghani, I.
    Hosseinpoor, S.
    Seyedmousavi, S.
    MYCOSES, 2017, 60 : 55 - 55
  • [42] Caspofungin activity against clinical isolates of fluconazole-resistant Candida
    Pfaller, MA
    Messer, SA
    Boyken, L
    Rice, C
    Tendolkar, S
    Hollis, RJ
    Diekema, DJ
    JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (12) : 5729 - 5731
  • [43] In vitro activity of amphotericin B, itraconazole, terbinafine and 5-fluocytosine against Exophiala spinifera and evaluation of post-antifungal effects
    Vitale, RG
    De Hoog, GS
    Verweij, PE
    MEDICAL MYCOLOGY, 2003, 41 (04) : 301 - 307
  • [44] Synergistic anticandidal activity of menthol in combination with itraconazole and nystatin against clinical Candida glabrata and Candida krusei isolates
    Sharifzadeh, Aghil
    Khosravi, Ali Reza
    Shokri, Hojjatollah
    Tari, Paria Samadi
    MICROBIAL PATHOGENESIS, 2017, 107 : 390 - 396
  • [45] Antifungal Activity of SCY-078 and Standard Antifungal Agents against 178 Clinical Isolates of Resistant and Susceptible Candida Species
    Schell, Wiley A.
    Jones, A. M.
    Borroto-Esoda, Katyna
    Alexander, Barbara D.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (11)
  • [46] Antifungal activity of cisatracurium against fluconazole-resistant Candida isolates and its antibiofilm effects
    do Nascimento, Francisca B. A.
    Sa, Livia G. A. Valente
    Neto, Joao B. de Andrade
    Cabral, Vitoria P. F.
    Rodrigues, Daniel S.
    Barbosa, Amanda D.
    Moreira, Lara E. A.
    Oliveira, Leilson C.
    Silva, Anderson
    Lima, Iri S. P.
    Silva, Jacilene
    Marinho, Emmanuel S.
    Santos, Helcio S.
    Cavalcanti, Bruno C.
    Morais, Manoel O.
    Helio, V. N.
    Silva, Cecilia R.
    FUTURE MICROBIOLOGY, 2023, : 649 - 660
  • [47] In vitro synergism of a water insoluble fraction of Uncaria tomentosa combined with fluconazole and terbinafine against resistant non-Candida albicans isolates
    Moraes, Renata Cougo
    Carvalho, Anderson Ramos
    Dalla Lana, Aline Jacobi
    Kaiser, Samuel
    Pippi, Bruna
    Fuentefria, Alexandre Meneghello
    Ortega, George Gonzalez
    PHARMACEUTICAL BIOLOGY, 2017, 55 (01) : 406 - 415
  • [48] In vitro activity of caspofungin compared to amphotericin B, fluconazole, and itraconazole against Candida strains isolated in a Turkish University Hospital
    Arikan, S
    Sancak, B
    Hascelik, G
    MEDICAL MYCOLOGY, 2005, 43 (02) : 171 - 178
  • [49] In vitro activity of amphotericin B, fluconazole and itraconazole against Candida glabrata strains isolated from clinical samples
    Avcilar, Huseyin
    Sancak, Banu
    Arikan, Sevtap
    MIKROBIYOLOJI BULTENI, 2007, 41 (02): : 235 - 244
  • [50] Susceptibility of fluconazole-resistant clinical isolates of Candida spp. to echinocandin LY303366, itraconazole and amphotericin B
    Cuenca-Estrella, M
    Mellado, E
    Díaz-Guerra, TM
    Monzón, A
    Rodríguez-Tudela, JL
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (03) : 475 - 477